Showing results (2061-2070 of 2,341) with videos related to

Sort By:
Pageof 235
Journal of Clinical and Translational Science|October 13, 2023
Uncovering key clinical trial features influencing recruitmentBetina Idnay, Yilu Fang, Alex Butler, et al.
ACR Open Rheumatology|September 21, 2022
Randomized Trial of Tocilizumab in the Treatment of Refractory Adult Polymyositis and DermatomyositisChester V Oddis, Howard E Rockette, Lei Zhu, et al.
Angewandte Chemie (International Ed. in English)|October 27, 2020
Synthetic Routes for Heteroatom-Containing Alkylated/Arylated Polycyclic Aromatic HydrocarbonsQinqin Shi, Xiaosong Shi, Changfu Feng, et al.
Schizophrenia Bulletin|June 14, 2015
Phase 2 Trial of an Alpha-7 Nicotinic Receptor Agonist (TC-5619) in Negative and Cognitive Symptoms of SchizophreniaDavid Walling, Stephen R Marder, John Kane, et al.
Schizophrenia Bulletin|July 5, 2015
Effort-Based Decision-Making Paradigms for Clinical Trials in Schizophrenia: Part 1—Psychometric Characteristics of 5 ParadigmsL Felice Reddy, William P Horan, Deanna M Barch, et al.
Archives of Neurology|April 12, 2006
Case-control study of the parkin gene in early-onset Parkinson diseaseLorraine N Clark, Shehla Afridi, Eric Karlins, et al.
JAMA Psychiatry|July 8, 2026
Toward a Pluralistic Model for the Schizophrenia Spectrum-Dopamine and BeyondMatcheri S Keshavan, Henry A Nasrallah, Anissa Abi-Dargham, et al.
The Journal of Physical Chemistry. A|April 23, 2009
Synthesis and photophysical properties of donor- and acceptor-substituted 1,7-bis(arylalkynyl)perylene-3,4:9,10-bis(dicarboximide)sZesheng An, Susan A Odom, Richard F Kelley, et al.
Journal of Neurochemistry|December 22, 2021
Colony-stimulating factor-1 receptor inhibition attenuates microgliosis and myelin loss but exacerbates neurodegeneration in the chronic cuprizone modelVictoria S B Wies Mancini, Anabella A Di Pietro, Soledad de Olmos, et al.
Pageof 235